NYSDA Publications

NIH Launches Another Phase 3 Clinical Trial for a Potential COVID-19 Vaccine

The National Institutes of Health (NIH) has launched a fourth Phase 3 clinical trial for a potential vaccine for the novel coronavirus (COVID-19).  NIH notes that the potential vaccine was developed by the Janssen Pharmaceutical Companies of Johnson & Johnson.  To read the NIH announcement and summary of the launch of a Phase 3 clinical trial for the Janssen COVID-19 vaccine, use the link below.